Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Artificial Disc Study
Clinical Trial Protocol ID
05010505

Clinical Trial Investigator Name
Frank Phillips, MD

Clinical Trial Title

A prospective, randomized clinical investigation of the Cervitech, Inc., porous coated motion artificial disc for stabilization of the cervical spine



Clinical Trial Protocol Description

The area of the spinal column in the neck region is called the cervical spine. The cervical spine is made up of seven bones, called vertebrae. These vertebrae are connected by several joints, which allow people to bend, twist and move the neck. The main joint between two vertebrae is called a disc. The disc is a soft spongy material that holds the two bones together while still allowing for movement. Because of the demands put on the disc, it sometimes can tear and wear down. This disease process is called degenerative disc disease (DDD).

DDD of the cervical spine can cause neck pain, along with pain, numbness, tingling, and/or weakness in the arms or shoulders. If more conservative treatment methods are not successful, the current standard treatment for these symptoms is to have surgery to remove the disc and then to fuse the two vertebrae together. This treatment usually relieves pain and other symptoms, but results in a loss of motion in the fused joint.

The purpose of this study is to evaluated whether the Porous Coated Motion Artificial Disc (PCM) is a safe and effective treatment for the symptoms described above. The PCM has been designed to support the spine, while preserving motion. The study will compare the outcome of disc surgery using the PCM artificial disc versus fusion surgery.

The PCM is a study device; it has not been approved by the Food & Drug Administration (FDA). The implant has three parts: two metal (cobalt chromium molybdenum alloy) endplates and one plastic (polyethylene) spacer. These materials are the same as the ones used for hip and knee replacements.

There will be about 825 subjects enrolled in this study from areas across the United States. Two-thirds of the subjects will have surgery to remove the damaged disc and replace it with the study device (PCM). The other subjects will receive the current standard treatment. They will have surgery to remove the damaged disc and then have the vertebrae fused together.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this trial if:

  • You are between the ages of 18 and 65
  • You have been diagnosed with radiculopathy or myelopathy of the cervical spine with either radiculopathy symptoms (pain, paraesthesias) or paralysis in a specific nerve root distribution from C4-C8 
  • You are symptomatic at only one level from C3-C4 to C7-T1
  • You have radiographically determined pathology at level to be treated correlating to primary symptoms

This is a partial list of eligibility criteria. If you would like to inquire about your eligibiility for this study, please call the number provided. If you choose to reply by e-mail, please include a phone number where you can be reached during the day and refer to the study title in your message.





Contact Name Margaret Hickey, RN, MS, MBA
Contact Phone (888) 362-3472
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Orthopedic Disorders Trials
Spine and Back Trials
Artificial Disc Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois